Insider trades
Eyal C. Attar, Chief Officer of Vor Biopharma VOR, has filed 0 purchases and 4 sales on the open market. The latest trade was on 25/02/13.
Eyal C. Attar
Chief Medical Officer
- Company
- Vor Biopharma VOR
- First filing
- 23/02/08
- Trades
- 28 trades
- Buys / sales
- 0 / 4
- 12-month net buying
- No record
- Last trade
- 25/02/13
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 25/02/13 | 25/02/18 | 2,227 sh | $1.42 | $3,162.34 | −1.7% | |
| Open-market sale10b5-1 plan | 25/02/10 | 25/02/12 | 2,554 sh | $1.37 | $3,498.98 | −1.9% | |
| Open-market sale10b5-1 plan | 24/12/27 | 24/12/31 | 10,334 sh | $1.25 | $12,917.5 | −11.3% | |
| Open-market sale10b5-1 plan | 24/06/03 | 24/06/04 | 14,645 sh | $1.39 | $20,356.55 | −13.2% |